Histological changes in endocrine and exocrine pancreatic tissue from patients exposed to incretin‐based therapies

Abstract

The present results did not reveal marked histological abnormalities in the pancreas of incretin-treated patients with type 2 diabetes. Low numbers of specimens available and a large inter-individual variability of the findings warrant caution regarding the interpretation of histological data concerning drug effects on the human pancreas.